Org Partners LLC Medicenna Therapeutics Corp. Transaction History

Org Partners LLC

  • $689 Million
  • Q4 2024

A detailed history of Org Partners LLC transactions in Medicenna Therapeutics Corp. stock. As of the latest transaction made, Org Partners LLC holds 175,000 shares of MDNA stock, worth $54,250. This represents 0.01% of its overall portfolio holdings.

Number of Shares
175,000
Previous 125,000 40.0%
Holding current value
$54,250
Previous $38,000 42.11%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025
BUY
N/A
50,000 Added 40.0%
175,000 $54,000
Q3 2024

Oct 11, 2024
BUY
N/A
25,000 Added 25.0%
125,000 $38,000
Q2 2024

Jul 16, 2024
BUY
N/A
100,000 New
100,000 $31,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
913K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email